date,title,source
Oct-17-18,"Market Trends Toward New Normal in Halozyme Therapeutics, Fitbit, Iconix Brand Group, Leap Therapeutics, LightPath Technologies, and Capricor Therapeutics  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Oct-22-18,Capricor Therapeutics to Participate in Upcoming Conferences,GlobeNewswire
Nov-06-18,Capricor Therapeutics to Present Third Quarter Financial Results and Corporate Update on November 13,GlobeNewswire
Nov-07-18,Analysts Estimate Capricor Therapeutics (CAPR) to Report a Decline in Earnings: What to Look Out for,Zacks
Nov-08-18,Capricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International Conference,GlobeNewswire
Nov-12-18,Capricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical Trial,GlobeNewswire
Nov-13-18,"Capricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-13-18,Capricor: 3Q Earnings Snapshot,Associated Press
Nov-13-18,Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-28-18,"Research Report Identifies OraSure Technologies, Sierra Wireless, Seres Therapeutics, Lydall, ChromaDex, and Capricor Therapeutics with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Dec-04-18,Could The Capricor Therapeutics Inc (NASDAQ:CAPR) Ownership Structure Tell Us Something Useful?,Simply Wall St.
Dec-26-18,U.S. drug developer Capricor places Duchenne drug trial on hold,Reuters
Dec-26-18,Capricor places Duchenne drug trial on hold,Reuters
Dec-27-18,"Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor Therapeutics, Appian, Yext, Agile Therapeutics, and Corbus Pharmaceuticals  New Research Emphasizes Economic Growth",GlobeNewswire
Jan-18-19,"Does Capricor Therapeutics, Inc.s (NASDAQ:CAPR) CEO Pay Reflect Performance?",Simply Wall St.
Jan-22-19,Capricor Announces Positive Outcomes from Comprehensive Multidisciplinary Meeting with FDA,GlobeNewswire
Jan-24-19,4 Healthcare Stocks Looking To Have A Strong Thursday (1/24/19),ACCESSWIRE
Jan-24-19,Neurology Publishes Study Reporting Significant Improvements in Duchenne Muscular Dystrophy Patients Treated with Capricors Novel Cell Therapy,GlobeNewswire
Feb-06-19,Capricor Resumes Dosing of Enrolled Patients in HOPE-2 Clinical Trial for Duchenne Muscular Dystrophy,GlobeNewswire
Feb-21-19,"Capricor Therapeutics, Inc. (NASDAQ:CAPR): Commentary On Fundamentals",Simply Wall St.
Mar-21-19,Capricor Therapeutics to Present Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Update on March 28,GlobeNewswire
Mar-28-19,Capricor: 4Q Earnings Snapshot,Associated Press
Mar-28-19,Capricor Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Apr-05-19,"Will Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Earnings Grow In The Years Ahead?",Simply Wall St.
May-13-19,"Capricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue Estimates",Zacks
May-13-19,Capricor: 1Q Earnings Snapshot,Associated Press
May-13-19,Capricor Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update,GlobeNewswire
May-13-19,"Capricor Therapeutics, Inc. to Host Earnings Call",ACCESSWIRE
